Cellular pharmacology of polynuclear platinum anti-cancer agents

Journal of Inorganic Biochemistry

Volumn 77, Issue 1-2, 1999, Pages 51-57

  Roberts, John D ^a,b   Peroutka, John ^c   Farrell, Nicholas ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NONE

Author keywords

Cellular pharmacology; Cisplatin; Polynuclear platinum

Indexed keywords

BBR 3005; BBR 3171; BBR 3464; CISPLATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CROSS RESISTANCE; DNA CROSS LINKING; DNA STRAND; DRUG CYTOTOXICITY; LEUKEMIA CELL; MOUSE; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; CROSS-LINKING REAGENTS; DNA ADDUCTS; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; INHIBITORY CONCENTRATION 50; LEUKEMIA L1210; ORGANOPLATINUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0033389389     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00147-6     Document Type: Article

References (24)

1. Christian M.C. Semin. Oncol. 19:1992;720.
2. Farrell N., Qu Y., Hacker M.P. J. Med. Chem. 33:1990;2179.
3. N. Farrell, in: L.H. Hurley and J.B. Chaires (Eds.) Advances in DNA Sequence Specific Agents, vol. 2, JAI Press Inc., New Haven, 1996, pp. 187-216.
4. Farrell N.P. Cancer Invest. 11:1993;578.
5. Farrell N.P., de Almeida S.G., Skov K.A. J. Am. Chem. Soc. 110:1988;5018.
6. N. Farrell, S. Spinelli, in: N. Farrell (Ed.), Uses of Inorganic Chemistry in Medicine, Royal Society of Chemistry, London, 1999, pp. 124-134.
7. N. Farrell, Y. Qu, U. Bierbach, M. Valsecchi, E. Menta, in: B. Lippert (Ed.), 30 Years of Cisplatin - Chemistry and Biochemistry of a Leading Anticancer Drug, Springer, Berlin, 1999, p. 479.
8. Rauter H., Di Domenico R., Menta E., Oliva A., Qu Y., Farrell N. Inorg. Chem. 36:1997;3919.
9. Manzotti C., Pezzoni G., Giuliani F., Valsecchi M., Farrell N., Tognella S. Proc. AACR. 35:1994;2628.
10. Farrell N., Appleton T.G., Qu Y., Roberts J.D., Soares Fontes A.P., Skov K.A., Wu P., Zou Y. Biochemistry. 34:1995;15480.
11. G. Pratesi, S.C. Righetti, R. Supino, D. Polizzi, C. Manzotti, F.C. Giuliani, G. Pezzoni, S. Tognella, S. Spinelli, P. Perego, N. Farrell, F. Zunino, Br. J. Cancer, in press.
12. Brabec V., Kašpárková J., Vrána O., Nováková O., Cox J., Qu Y., Farrell N. Biochemistry. 38:1999;6781.
13. DiBlasi P., Bernaregi A., Begiolin G., Piazoni L., Menta E., Formento M.L. Anticancer Res. 18:1998;3113.
14. Eastman A., Illenye S. Cancer Treat. Rep. 68:1984;1189.
15. Hacker M. P., Khokhar A.R., Brown D.B., McCormack J.J., Krakoff I.H. Cancer Res. 45:1985;4748.
16. Roberts J.D., Schmidt W.J., Tong W.P., Hacker M.P. Inorg. Chim. Acta. 153:1988;123.
17. Eastman A. Anal. Biochem. 197:1991;311.
18. Kohn K.W. Pharmac. Ther. 49:1991;55.
19. G. Los, D. Gately, M.L. Costello, F. Thiebaut, P. Naredi, S.B. Howell, in: H.M. Pinedo, J.M. Schornagel (Eds.), Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2, Plenum, New York, 1996.
20. Micetich K.C., Barnes D., Erickson L.C. Cancer Res. 45:1985;4043.
21. Kasparkova J., Novakova O., Vrana O., Farrell N., Brabec V. Biochemistry. 38:1999;10997.
22. A. Eastman, N. Schulte, N. Sheibani, C.N. Sorenson, in: N. Nicolini (Ed.), Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, Martinus Nijhoff, Boston, 1988, pp. 178-196.
23. Eastman A., Schulte N. Biochemistry. 27:1988;4730.
24. Perego P., Caserini C., Gatti L., Carenini N., Romanelli S., Supino R., Colangelo D., Viano I., Spinelli S., Pezzoni G., Manzotti C., Farrell N., Zunino F. Mol. Pharmacol. 55:1999;528.